Same Indication

Desoxyribonuclease vs Trastuzumab

Desoxyribonuclease vs Trastuzumab: Overview

This comparison examines the pharmacological differences between Desoxyribonuclease and Trastuzumab.

Mechanism of Action

Trastuzumab: Anti-HER2 monoclonal antibody inhibiting receptor signaling.

Pharmacokinetics

Half-life: Trastuzumab β€” 28 days.

Chemical Properties

Type: Desoxyribonuclease β€” Enzyme; Trastuzumab β€” Antibody.